These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26657058)

  • 21. New insights into pharmacological tools to TR(i)P cancer up.
    Gautier M; Dhennin-Duthille I; Ay AS; Rybarczyk P; Korichneva I; Ouadid-Ahidouch H
    Br J Pharmacol; 2014 May; 171(10):2582-92. PubMed ID: 24345078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRPC5 in cardiovascular diseases.
    Du SL; Jia ZQ; Zhong JC; Wang LF
    Rev Cardiovasc Med; 2021 Mar; 22(1):127-135. PubMed ID: 33792254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A methylation-based regulatory network for microRNA 320a in chemoresistant breast cancer.
    He DX; Gu XT; Jiang L; Jin J; Ma X
    Mol Pharmacol; 2014 Nov; 86(5):536-47. PubMed ID: 25159093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryo-EM structure of TRPC5 at 2.8-Å resolution reveals unique and conserved structural elements essential for channel function.
    Duan J; Li J; Chen GL; Ge Y; Liu J; Xie K; Peng X; Zhou W; Zhong J; Zhang Y; Xu J; Xue C; Liang B; Zhu L; Liu W; Zhang C; Tian XL; Wang J; Clapham DE; Zeng B; Li Z; Zhang J
    Sci Adv; 2019 Jul; 5(7):eaaw7935. PubMed ID: 31355338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gs cascade regulates canonical transient receptor potential 5 (TRPC5) through cAMP mediated intracellular Ca2+ release and ion channel trafficking.
    Hong C; Kim J; Jeon JP; Wie J; Kwak M; Ha K; Kim H; Myeong J; Kim SY; Jeon JH; So I
    Biochem Biophys Res Commun; 2012 Apr; 421(1):105-11. PubMed ID: 22490661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRP channels in kidney disease.
    Hsu YJ; Hoenderop JG; Bindels RJ
    Biochim Biophys Acta; 2007 Aug; 1772(8):928-36. PubMed ID: 17346947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of functional ion-channel tools by E3 targeting.
    Xu SZ; Zeng F; Lei M; Li J; Gao B; Xiong C; Sivaprasadarao A; Beech DJ
    Nat Biotechnol; 2005 Oct; 23(10):1289-93. PubMed ID: 16170312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical roles of Gi/o proteins and phospholipase C-δ1 in the activation of receptor-operated TRPC4 channels.
    Thakur DP; Tian JB; Jeon J; Xiong J; Huang Y; Flockerzi V; Zhu MX
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1092-7. PubMed ID: 26755577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRPC channels as effectors of cardiac hypertrophy.
    Eder P; Molkentin JD
    Circ Res; 2011 Jan; 108(2):265-72. PubMed ID: 21252153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRP channels: an overview.
    Pedersen SF; Owsianik G; Nilius B
    Cell Calcium; 2005; 38(3-4):233-52. PubMed ID: 16098585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heteromultimeric TRPC6-TRPC7 channels contribute to arginine vasopressin-induced cation current of A7r5 vascular smooth muscle cells.
    Maruyama Y; Nakanishi Y; Walsh EJ; Wilson DP; Welsh DG; Cole WC
    Circ Res; 2006 Jun; 98(12):1520-7. PubMed ID: 16690880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine.
    Nilius B; Szallasi A
    Pharmacol Rev; 2014 Jul; 66(3):676-814. PubMed ID: 24951385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in vascular endothelial cell transient receptor potential channels.
    Yao X; Garland CJ
    Circ Res; 2005 Oct; 97(9):853-63. PubMed ID: 16254217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeutics.
    Gaunt HJ; Vasudev NS; Beech DJ
    Eur Biophys J; 2016 Oct; 45(7):611-620. PubMed ID: 27289383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological manipulation of TRPC5 by kaempferol attenuates metastasis of gastrointestinal cancer via inhibiting calcium involved in the formation of filopodia.
    Yu S; Deng R; Wang W; Zou D; He L; Wei Z; Pan Y; Li X; Wu Y; Wang A; Chen W; Zhao Y; Lu Y
    Int J Biol Sci; 2024; 20(12):4922-4940. PubMed ID: 39309444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of TRPC1 and TRPC5 in medial temporal lobe structures of mice.
    von Bohlen Und Halbach O; Hinz U; Unsicker K; Egorov AV
    Cell Tissue Res; 2005 Nov; 322(2):201-6. PubMed ID: 16044320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transient receptor potential, TRP channels: a new family of channels broadly expressed].
    Vassort G; Fauconnier J
    Med Sci (Paris); 2008 Feb; 24(2):163-8. PubMed ID: 18272078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRPC3: a multifunctional, pore-forming signalling molecule.
    Eder P; Poteser M; Groschner K
    Handb Exp Pharmacol; 2007; (179):77-92. PubMed ID: 17217051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
    Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance.
    Ma X; Chen Z; Hua D; He D; Wang L; Zhang P; Wang J; Cai Y; Gao C; Zhang X; Zhang F; Wang T; Hong T; Jin L; Qi X; Chen S; Gu X; Yang D; Pan Q; Zhu Y; Chen Y; Chen D; Jiang L; Han X; Zhang Y; Jin J; Yao X
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6389-94. PubMed ID: 24733904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.